Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
14.1M
-
Shares change
-
-3.65M
-
Total reported value, excl. options
-
$35M
-
Value change
-
-$11M
-
Put/Call ratio
-
0.39
-
Number of buys
-
39
-
Number of sells
-
-52
-
Price
-
$2.49
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2022
109 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q2 2022.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.1M shares
of 43.4M outstanding shares and own 32.44% of the company stock.
Largest 10 shareholders include Prosight Management, LP (1.66M shares), VANGUARD GROUP INC (1.52M shares), Slate Path Capital LP (1.48M shares), BlackRock Inc. (832K shares), SANDERS MORRIS HARRIS LLC (736K shares), DIMENSIONAL FUND ADVISORS LP (669K shares), MILLENNIUM MANAGEMENT LLC (602K shares), CARLSON CAPITAL L P (580K shares), RENAISSANCE TECHNOLOGIES LLC (580K shares), and Bleichroeder LP (555K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.